The Latin America, Middle East and Africa Colposcopes Market would witness market growth of 6.5% CAGR during the forecast period (2020-2026).
The size of the market for colposcopy is projected to see substantial growth owing to the growing incidences of cervical cancer across the globe. The main use of colposcopy is identifying precancerous tissues to avoid cervical cancer. According to the World Health Organization (WHO), cervical cancer is listed as the world’s second-most common cause of death from cancer in women.
The cancer burden is rising among women in both high-income (HIC) and low- and middle-income (LMIC) countries owing to shifts in the prevalence of cancer risk factors as countries experience economic transformation. The major risk factors include changing patterns of lifestyle, smoking, physical inactivity, excess body weight, and changes in reproductive patterns such as late first birth, as well as fewer births. Therefore, a higher prevalence of cervical cancer due to the above-mentioned factors will drive colposcope market growth worldwide.
Cervical cancer is most commonly diagnosed in women between the ages of 35 and 44 with an average age being 50 at diagnosis. It only occurs in females below 20. A lot of older women do not realize that there is still a risk of developing cervical cancer as they age. Screening involves screening for cancer before a person has any symptoms. This will help detect cancer at an early level. If abnormal tissue or cancer is found early, it may be easier to treat. When symptoms appear, cancer may have begun to spread. Scientists are seeking to understand better which population segment is more likely to get other forms of cancer. They even research the things that a person does and the things that affect them and see whether certain habits or routine causes cancer. This information helps doctors recommend who should be screened for cancer, what screening tests should be used, and how often the tests should be performed.
Based on Application, the market is segmented into Cervical cancer screening and Physical examinations. Based on Product, the market is segmented into Portable, Handheld and Stationary. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Microsystem GmbH), McKesson Corporation, Olympus Corporation, Carl Zeiss AG, The Cooper Companies, Inc., DYSIS Medical Ltd., ATMOS MedizinTechnik GmbH & Co. KG, OPTOMIC, Seiler Instrument, Inc., and Gynex Corporation.
Scope of the Study
• Cervical cancer screening and
• Physical examinations
• Handheld and
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Danaher Corporation (Leica Microsystem GmbH)
• McKesson Corporation
• Olympus Corporation
• Carl Zeiss AG
• The Cooper Companies, Inc.
• DYSIS Medical Ltd.
• ATMOS MedizinTechnik GmbH & Co. KG
• Seiler Instrument, Inc.
• Gynex Corporation
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
The alpha emitter market is expected to witness a healthy CAGR of 36.7% during the forecast period (2020 - 2025). Certain factors that are driving the market growth include increased awareness about the potential benefits of targeted alpha therapy and the growing number of patients with cardiac and cancer ailments. Targeted anticancer...
Nanoscale technology is widely used in medical devices and medicine where manipulations are made at the molecular level, taking advantage of the novel properties of a material. The primary demand of this field in medicine is in making improvements in the delivery of treatments and healthcare outcomes. Nanomedicine refers to the usage of nanoscale...
Certain factors that are driving the market growth include the increased incidence of cancer, globally, and higher acceptance of treatments for cancer in the developing regions, the paradigm shift in healthcare, from disease diagnosis to risk assessment or early diagnosis, and increasing usage of biomarkers in drug development. - Globally,...
The global cold plasma equipment market is expected to reach US$ 308.14 Mn in 2027 from US$ 96.67 Mn in 2019. The market is estimated to grow with a CAGR of 15.7% from 2020-2027. The growth of the cold plasma equipment market is primarily attributed to the factors such as increasing use of cold plasma in medical treatment, increasing hospital...
The global cancer tissue diagnostics market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027. The market for cancer tissue diagnostics is expected to grow, owing to factors such as growing cancer prevalence across the globe, new product launches &...
Gastrointestinal Stents Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Gastrointestinal Stents Market Size, Outlook and Growth Opportunities to 2025: By Product (Biliary Stents, Colonic Stents, Duodenal Stents, Pancreatic Stents, and Esophageal Stents), By Material (Self-Expanding Metal Stents, Plastic...
Middle East and Africa cancer screening market The Middle East and Africa (MEA) cancer screening market is growing at a very slow rate. The MEA market is projected to reach USD 50.61 Bn by 2023, at a compound annual growth rate (CAGR) of 11.5% during the forecast period (2018-2023).The United Arab Emirates (UAE), Saudi Arabia and Kuwait...
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Multiple Myeloma in 18 Major Markets
Multiple Myeloma is a cancer of plasma cells and is characterized by the production of abnormal immunoglobulins (Ig) or antibodies, as well as an accumulation of malignant plasma cells in the bone marrow. In some cases it...
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Brain & CNS Cancer in 19 Major Markets
Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than...
Diagnostic Imaging Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.